Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Walgreens Boots Alliance (NQ: WBA )

8.300 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Walgreens Boots Alliance

< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
The Boulder Group Arranges Sale of Net Leased Chipotle Property in Chicago MSA
Via AB Newswire
WALGREENS BOOTS ALLIANCE, INC. (NASDAQ: WBA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Walgreens Boots Alliance, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Check Out What Whales Are Doing With WBA
Via Benzinga
Large-Cap Stocks In Trouble: The 10 Worst Performers - Sunday, Aug. 25
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps with their one-year price returns. 
Via Talk Markets
3 Struggling Stocks That Aren't Worth Buying on the Dip
These stocks are all down more than 30% in just three months. 
Via The Motley Fool
Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms
Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR. 
Via Benzinga
Walgreens Is Reportedly Considering a Drastic Move to Improve Its Cash Flow
Will Walgreens dump its stake in VillageMD? 
Via The Motley Fool
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBA
From The Rosen Law Firm PA
Via GlobeNewswire
How To Build A Dividend Growth Portfolio In An Overpriced Market
The stock market as measured by the S&P is currently at an all-time high which makes it very challenging to try to build a quality dividend growth portfolio. 
Via Talk Markets
Topics Stocks
Exposures US Equities
America's Future: Walgreens Versus Costco
Via Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
With Shares Down Over 60%, Is Now the Time to Buy This Healthcare Stock?
Should investors consider buying Walgreens at current depressed levels? 
Via The Motley Fool
3 Brand-Name Ultra-High-Yield Dividend Stocks Billionaires Can't Stop Buying
Despite these high-octane income stocks badly underperforming in the current bull market, billionaire money managers can't get enough of them. 
Via The Motley Fool
The Boulder Group Arranges Sale of Net Lease Caliber Collision Property in Michigan
Via AB Newswire
Auto Stocks, Abortion, Health Care In Spotlight At DNC: Joe Biden, UAW President, Women Affected By Roe V. Wade Decision Headline Night 1
The first night of the Democratic National Convention (DNC) could have investors eyeing sectors like healthcare and automotive after key speeches. 
Via Benzinga
WALGREENS BOOTS ALLIANCE, INC. (NASDAQ: WBA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Walgreens Boots Alliance, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Walgreens and BARDA Form Strategic Partnership to Strengthen Decentralized Clinical Trials Model and Reporting
From Walgreens
Via Business Wire
Pharmacy Chains Like CVS Health, Walgreens Boots Alliance Confront Shifting Consumer Habits And Profit Pressures
Walgreens and CVS face declining profits as falling reimbursement rates, rising costs, and competition challenge the retail pharmacy model. Both companies are rethinking strategies, including store... 
Via Benzinga
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Walgreens Stock
The company is relatively generous, but that hasn't made its shares popular. 
Via The Motley Fool
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers
Over the past twelve months, 10 large-cap stocks have underperformed all others. Here’s this week’s list of the top 10 worst performing large-caps. 
Via Talk Markets
Is Cash Flow a Problem for Walgreens Boots Alliance?
There are plenty of red flags surrounding the business. 
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Walgreens Appoints Two New Leaders to its Retail and Customer Experience Team
From Walgreens
Via Business Wire
3 Top Dividend ETFs That Investors can Buy and Hold for Decades
You won't have to worry about tracking individual dividend stocks anymore with these funds. 
Via The Motley Fool
Topics ETFs
3 Ultra-High Dividend Stocks Yielding Over 7%
High dividend stocks are particularly appealing in a declining interest rate environment. 
Via Talk Markets
Instacart Stock Gains Momentum with Profits and AI-Powered Carts
Online grocery marketplace and delivery service company Maplebear Inc. (NASDAQ: CART) operates as Instacart. Instacart has had over 25 million customers 
Via MarketBeat
WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.